dpp-4 inhibitors vs. glp-1 agonist Role of Dipeptidyl Peptidase 4 in Antidiabetic Treatment GLP-1-RA and DPP-4 inhibitors in
Description
Glucagon-like peptide-1: from extract to agent
The combination of fiber, healthy fats, and lean protein creates multiple opportunities for nutrient-stimulated hormone responses throughout the day
Its GLP-1 drug semaglutide failed to treat Alzheimers across two large trials
Thiazolidinediones (TZDs): Enhance peripheral insulin sensitivity
When BMI and comorbidity thresholds are met for anti obesity pharmacotherapy, GLP-1 agonists are recommended as first line or preferred pharmacologic options because of superior weight loss efficacy and cardiometabolic benefit
[DOI] [PubMed] [Google Scholar] 24.Gaspari T., Welungoda I., Widdop R.E., Simpson R.W., Dear A.E
